Breast cancer: Who does not need chemotherapy?doi:10.1016/j.jgo.2013.09.208WildiersH.ESJournal of Geriatric Oncology
In most cases, the biggest life-changing effects ofbreast cancercome from the treatment, not from the disease. Early detection and therapy options make the outlook for most types of breast cancer very good. But surgery, chemotherapy, and radiation – while key parts of treatment – can take a...
Primary chemotherapy, in combination with radiotherapy and/or surgery, has been used in the treatment of advanced carcinoma of the breast for several decades. The term often used for this type of treatment is "neoadjuvant chemotherapy." More recently, less advanced cases of breast carcinoma have ...
Targeted therapiesthat go after cancer cells with less impact on healthy cells than chemotherapy Immunotherapyto encourage your body’simmune systemto attack cancer cells Even after treatment, you may need: Visits to an oncologist, every few months at first and then once a year after 5 years ...
Knowledge regarding how tumors evolve during treatment and whether subtype is influenced by neoadjuvant chemotherapy (nCT) is limited. The purpose of this study was to compare the HR and HER2 status between core needle biopsy and residual tumor after surgery of breast cancer patients treated with ...
trial that included 2,199 people from 31 different countries with stage two or three triple negative breast cancer. Following surgery to remove their cancer, half of the patients were randomly assigned to be treated with chemotherapy plus atezolizumab, with the other half treated with chemotherapy....
How Cancer Causes Death Whether or not you will die if you have cancer depends on several factors, like the stage of the cancer. For example, terminal cancer cannot be cured but can be treated. It’s sometimes also called end-stage cancer. Any type of cancer can become terminal cancer, ...
When women with early-stage breast cancer were asked to rate the survival benefit that would justify 6 months of adjuvant chemotherapy, most of them considered the treatment worthwhile for relatively modest DFS improvements [59, 60]. Similarly, patients with low-risk melanoma were willing to ...
Oncologic Safety of Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy for Breast Cancer Article 23 October 2020 Introduction In breast cancer patients with clinically node-positive disease at presentation (cN +), axillary lymph node dissection (ALND) may be avoided after neoadjuvant sys...
Impact of Neoadjuvant Chemotherapy on Breast Cancer Subtype: Does Subtype Change and, if so, How? : IHC Profile and Neoadjuvant Chemotherapy.Background: Breast cancer subtype, as determined by the expression of estrogen receptor (ER) ... LCLM De,MO Harhay,P Zhang,... - 《Annals of Surgica...